Tirzepatide – perVial.com

Posted on August 28, 2026 by pervial

Tirzepatide in Emerging Indications: Liver, Kidney, and Cardiovascular Research

3D visualization of dual incretin peptide receptor interaction with surrounding cellular structures.

While approved for diabetes and weight management, tirzepatide is under active investigation for broader cardiometabolic indications. Emerging clinical tri

Posted on August 25, 2026 by pervial

Tirzepatide Clinical Evidence: What the SURPASS and SURMOUNT Trials Show

3D visualization of dual incretin peptide interacting with transmembrane cell receptors.

A comprehensive review of the clinical evidence for tirzepatide, examining glycemic and weight loss outcomes across the landmark SURPASS and SURMOUNT phase

Posted on August 22, 2026 by pervial

Tirzepatide in Metabolic Research: A Minto Pyramid Profile of Dual GIP/GLP-1 Receptor Agonism

A structured Minto Pyramid review examining tirzepatide’s pharmacology, evidence hierarchy, and dual GIP/GLP-1 receptor agonism in metabolic and endocrine